Compared with other breast cancer subtypes, TNBC is more likely to be diagnosed in younger women and is more likely to have metastases present at the time of diagnosis.
Changes in purchasing behavior have immediate and long-term effects on health care costs for both individuals and employers.
Health care providers—including physicians, oncologists, and specialty pharmacists—must leverage their collective resources and expertise to work together to address adherence on a larger scale.Â
Among psoriasis patients initiated on oral nonbiologic or on biologic therapy, most patients undergo at least 1 therapy change within 4 months of treatment initiation.
2019 Pharmacy Quality Alliance Annual Meeting included discussions on measures to improve medication services and how pharmacists can play a larger role in the multidisciplinary care team.
At minimum, they should engage in compliance risks; financial opportunities; key advocacy efforts; and program resources, structure, and value.
Animal products are prevalent in pharmaceuticals manufacturing, including in some unexpected places.
We assessed time to maintenance dose attainment in commercially insured men initiating topical testosterone agents and compared daily maintenance doses and costs of this therapy.
Pharmacists must continue to evolve to the needs of their patients and always remain a key player in health care decisions.
Compounded drugs accounted for more than half of cost increases under Medicare Part D in the last year.
Pharmacist-administered vaccination services were found to be more efficient, productive, and cost-effective than primary care visits or mass vaccination clinics.
Although its organizational infrastructure is virtual, the Community Pharmacy Foundation (CPF) is ‘anything but’ and is quite quantifiable and impactful in its vision, mission, and deliverables.
Pharmacists in all health care settings play an important role in the prevention and treatment of diabetic neuropathy.
USP Chapter presents many challenges for pharmacies and other health care settings, especially compounding pharmacies.
Isatuximab-ifrc is the third monoclonal antibody approved for the treatment of R/R MM.
Drug diversion in hospitals continues to be problematic. Heightened DEA activity and opioid addiction reaching epidemic proportions require hospitals to be more vigilant than ever.
The clinical assessment has long been a cornerstone of patient-centric specialty pharmacy care.
"The total time that I spent with this man was less than 20 minutes, but the impact that I had on his life when he thought he was all alone will last a lifetime."